Cover Image
市場調查報告書

全球微型核糖核酸市場未來展望

Global miRNA Market Outlook to 2018

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 226592
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
全球微型核糖核酸市場未來展望 Global miRNA Market Outlook to 2018
出版日期: 2014年08月01日 內容資訊: 英文 80 Pages
簡介

近幾年微型核糖核酸的發現與在廣泛領域的利用,聚集全世界的研究人員和企業的高度興趣。還有,全球各國組織了許多臨床實驗,進行對各種疾病的潛在效果研究。譬如,關於癌症治療,微型核糖核酸所扮演的角色,在美國、英國、法國、以色列、中國等研究進行中。目前研究開發的焦點領域,為診斷過程(表現圖譜、應答評估、潛在生物標記設定等)中微型核糖核酸的有效利用,微型核糖核酸的類似體、抑制劑的遺傳基因翻譯控制的有效利用等。這個市場還處於初期階段,不過以急劇的氣勢成長,隨新加入企業的增加,企業間的產業聯盟和研究機關的合作也取得進展。

本報告提供全球各國的miRNA(微型核糖核酸的研究相關市場相關分析)、最新的研究開發趨勢和預期利用領域、主要國家的開發趨勢、主要企業簡介與措施等資訊。

第1章 分析師的見解

第2章 分析方法

第3章 微型核糖核酸:簡介

第4章 微型核糖核酸技術

  • 微型核糖核酸的淨化
  • 微型核糖核酸的標籤
  • 微型核糖核酸的線性擴增
  • 微型核糖核酸的微陣列
  • 微型核糖核酸的qRT-PCR(定量即時、聚合酵素鏈鎖反應)
  • 微型核糖核酸的抑制
  • 微型核糖核酸的引進

第5章 全球微型核糖核酸市場未來展望

  • 微型核糖核酸的工具及服務市場
  • 各地區狀況
    • 南北美洲
    • 歐洲
    • 亞太地區(APAC)

第6章 目前微型核糖核酸的研究情形:各疾病

  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 氣喘
  • 肝炎

第7章 主要企業

  • Qiagen
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Life Technologies Corporation
  • Affymetrix
  • Integrated DNA Technologies
  • Exiqon
  • Mirus Bio
  • 和光純藥工業

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of miRNA in diverse fields such as Cancer, Asthma, Heart Disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market Outlook to 2018”, provides an in-depth analysis of the various aspects of miRNA at the industry as well as the research front.

The report covers present and future outlooks for the two broad categories of miRNA; tools and services segments. The former comprises various tools that are used to study miRNA. These include isolation kits, PCR arrays, labels, markers, mimics and inhibitors. On the other hand, the latter includes various services such as purification, expression profiling, quantification and analysis that are offered by miRNA players.

The market has been divided into three sections -The Americas, Europe and Asia Pacific. These regions have then been analyzed to draw patterns in terms of research areas and applicability. A brief look at the market suggests that cancer is the most researched topic and regions such as United States, United Kingdom, France, Israel and China are the major players interested in evaluating the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic purposes such as expression profiling, response evaluation and setting potential biomarkers in diseases. Another application is in the field of therapeutics where miRNA mimics and inhibitors are applied to control gene translation and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market players which are engaged in providing miRNA based tools and services. These players are working over a vast variety of products such as miRNA extraction and purification kits, and miRNA mimics and inhibitors, and constantly upgrading their portfolio to keep up with the latest developments in the field. Some of these players include Qiagen, Life Technologies, Exiqon and Mirus Bio.

Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the miRNA market is bound to witness rampant diversification and growth in the coming years.

Table of Contents

1. Analyst View

2. Research Methodology

3. miRNA - An Introduction

4. miRNA Techniques

  • 4.1. miRNA Purification
  • 4.2. miRNA Labeling
  • 4.3. miRNA Linear Amplification
  • 4.4. miRNA Microarrays
  • 4.5. miRNA qRT-PCR
  • 4.6. miRNA Inhibition
  • 4.7. miRNA Transfection

5. Global miRNA Market Outlook to 2018

  • 5.1. miRNA Tools and Services Market
  • 5.2. By Geography
    • 5.2.1. The Americas
    • 5.2.2. Europe
    • 5.2.3. Asia Pacific (APAC)

6. Ongoing miRNA Research by Disease

  • 6.1. Cancer
  • 6.2. Cardiovascular Diseases
  • 6.3. Metabolic Diseases
  • 6.4. Asthma
  • 6.5. Hepatitis

7. Key Players

  • 7.1. Qiagen
  • 7.2. Sigma-Aldrich Corporation
  • 7.3. Thermo Fisher Scientific Inc.
  • 7.4. Agilent Technologies Inc.
  • 7.5. Life Technologies Corporation
  • 7.6. Affymetrix
  • 7.7. Integrated DNA Technologies
  • 7.8. Exiqon
  • 7.9. Mirus Bio
  • 7.10. Wako Pure Chemical Industries

List of Figures:

  • Figure 3-1: miRNA Biogenesis
  • Figure 5-1: Global - miRNA Market (Million US$), 2012-2018
  • Figure 5-2: Global - miRNA Tools Market (Million US$), 2012-2018
  • Figure 5-3: Global - miRNA Services Market (Million US$), 2012-2018
  • Figure 5-4: Ongoing miRNA Research by Geography (%), 2013
  • Figure 5-5: The Americas - miRNA Market (Million US$), 2012-2018
  • Figure 5-6: The Americas - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-7: Europe - miRNA Market (Million US$), 2012-2018
  • Figure 5-8: Europe - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-9: Europe - Ongoing miRNA Research by Country (%), 2013
  • Figure 5-10: APAC - miRNA Market (Million US$), 2012-2018
  • Figure 5-11: APAC - Ongoing miRNA Research by Disease (%), 2013
  • Figure 5-12: APAC - Ongoing miRNA Research by Country (%), 2013
  • Figure 6-1: Ongoing miRNA Research by Disease (%), 2013
  • Figure 6-2: Cancer - Ongoing miRNA Research (%), 2013

List of Tables:

  • Table 4-1: miRNA Purification Products by Supplier
  • Table 4-2: miRNA Labeling Products by Supplier
  • Table 4-3: miRNA Linear Amplification Products by Supplier
  • Table 4-4: miRNA Microarray Products by Supplier
  • Table 4-5: miRNA qRT-PCR Products by Supplier
  • Table 4-6: miRNA Inhibition Products by Supplier
  • Table 4-7: miRNA Transfection Products by Supplier
  • Table 5-1: The Americas - Ongoing miRNA Research (2013)
  • Table 5-2: Europe - Ongoing miRNA Research (2013)
  • Table 5-3: APAC - Ongoing miRNA Research (2013)
  • Table 6-1: miRNAs Associated with Cancer
  • Table 6-2: miRNAs Associated with Cardiovascular Diseases
  • Table 6-3: miRNAs Associated with Metabolic Disorders
  • Table 6-4: miRNAs Associated with Hepatitis
  • Table 7-1: Qiagen - miRNA Associated Product Line
  • Table 7-2: Sigma Aldrich - miRNA Associated Product Line
  • Table 7-3: Thermo Fisher - miRNA Associated Product Line
  • Table 7-4: Agilent - miRNA Associated Product Line
  • Table 7-5: Life Technology - miRNA Associated Product Line
  • Table 7-6: Affymetrix - miRNA Associated Product Line
  • Table 7-7: IDT - miRNA Associated Product Line
  • Table 7-8: Exiqon - miRNA Associated Product Line
  • Table 7-9: Mirus Bio - miRNA Associated Product Line
  • Table 7-10: Wako - miRNA Associated Product Line
Back to Top